课题基金 / 基金详情

Biophysical studies of oncogenic Cdc42Hs constructs

Biophysical studies of oncogenic Cdc42Hs constructs
致癌 Cdc42Hs 构建体的生物物理研究
批准号:
7201874
负责人:
PAUL Damien ADAMS
金额:
$11.36万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-10 至 2012-08-31
关键词:
AccountingAffectAffinityAmino AcidsAntineoplastic AgentsAreaBehaviorBindingBinding ProteinsBiologicalBiological ProcessBreastCell ProliferationCell Signaling ProcessCell physiologyChimera organismCollaborationsColonDataData AnalysesDefectDevelopmentDevelopment PlansDissociationDrug DesignEventExhibitsFluorescenceFluorescence SpectroscopyForms ControlsFosteringFoundationsFutureGTP BindingGTP-Binding ProteinsGenus ColaGoalsGuanine Nucleotide Dissociation InhibitorsGuanine NucleotidesGuanosine DiphosphateGuanosine TriphosphateGuanosine Triphosphate PhosphohydrolasesHRAS geneHumanHydrolysisInvestigationLeadLightLungMalignant NeoplasmsMediatingMentorsMethodsModelingMolecularMolecular ConformationMolecular MedicineMutationNMR SpectroscopyNatureNeoplasm MetastasisNucleotidesOncogenicPeptidesPharmaceutical PreparationsPhasePhosphotransferasesPreparationProceduresProcessProtein RegionProteinsRateRelative (related person)ResearchSignal PathwaySignal TransductionSignal Transduction PathwaySignaling ProteinSolutionsSpecificityStructureStructure-Activity RelationshipTechniquesTestingTherapeuticTimeTumor Cell InvasionUniversitiesWorkbasecancer cellcancer therapycareercell transformationcell typechemotherapydefined contributiondesignexperiencegenetic regulatory proteinguanine nucleotide binding proteininhibitor/antagonistinnovationmembermetaplastic cell transformationmouse Gdi2 proteinmutantprogramsprotein protein interactionprotein structureras Proteinsrhostructural biologysuccesstherapeutic targettooltumorigenesis

项目摘要

项目成果

PAUL Damien ADAMS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cdc42Hs, a member of the Ras superfamily signal transduction proteins, binds guanine nucleotides and acts as a molecular timing switch in multiple signal transduction pathways. This proposal is centered around studying the structure and dynamics of Cdc42Hs forms associated with its oncogenic potential and will provide atomic level information into mechanisms that regulate this activity. The Cdc42Hs constructs that will be studied are, A) Cdc42Hs(nucleotide-free) and, B) Cdc42Hs(F28L_?L8). Defining the structure and dynamics of the nucleotide-depleted form of Cdc42Hs will shed light on the conformation(s) of Cdc42Hs that facilitate the binding of protein effectors, such as Dbl, that stimulate oncogenic activity. The study of the structure and dynamics of Cdc42Hs(F28L_?L8) should reveal information on interactions in Cdc42Hs that block oncogenic activity caused by the single mutant Cdc42Hs(F28L). The immediate goals of this research are to use NMR and fluorescence as structural techniques to gain a better understanding of the processes by which changes in Cdc42Hs and its interaction with regulators affect various important signal transduction pathways that lead to cancer. The long-term goals of this proposed research are to gain a better understanding of how protein structure and dynamics correlate with aberrant cell function, which will lay the foundation for future research into the development of a rational anti-cancer drug design program. Cdc42Hs is a member of the Ras superfamily of proteins, which have been implicated in cancers in the colon, breasts, and lungs. These studies will provide information on particular aspects of specific cell-signaling processes that may be subsequently used in the development of new anti-cancer treatments that are specific and may be less toxic than traditional chemotherapy approaches. I have a background in the use of fluorescence spectroscopy in the study of biological molecules and have used NMR spectroscopy to study structure of small peptides in solution. The mentored phase of this proposal will provide me with the opportunity to gain experience in several uses of these techniques that have not yet been mastered that will be crucial to my transition to independent investigation. The Department of Molecular Medicine at Cornell University has great experience in the area of applying physical methods to biological processes, and in particular, signal transduction. It is an excellent setting for this project, and also to foster the development of my career. The research career development plan of this proposal is two-phased. Phase I (Mentored) will allow for the study of the nucleotide-free construct of Cdc42Hs. The experience with the structural tools, data analysis procedures, and scientific collaboration in this phase will foster the necessary preparation for a successful transition into Phase II (Independent), during which time I will study the structure and dynamics of Cdc42Hs(F28L_?L8), leading to further research in the structural biology of biomolecules related to cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monovalent Nanocrystals for Biomedical Imaging
Biophysical studies of oncogenic Cdc42Hs constructs
Monovalent Nanocrystals for Biomedical Imaging
Biophysical studies of oncogenic Cdc42Hs constructs
海外基金